Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults

Gastroenterology
P HildebrandA K Khan

Abstract

In developing countries where Helicobacter pylori infection is widespread, posttherapeutic recurrence rates may be high. Many of the limited studies available have methodological problems and show varied recurrence rates. We determined late recrudescence rates, true reinfection, and ulcer recurrence. One hundred five Bangladeshi patients with H. pylori infection and duodenal ulcer disease were treated with a triple therapy. Follow-up included 13C-urea breath tests, endoscopy, and biopsy-based tests. In reinfected patients, genomic typing compared pretherapeutic and posttherapeutic strains. Recrudescence, associated with nitroimidazole-based treatment, occurred in 15 of 105 patients (14%) within the first 3 months, but only 8 of 105 patients tested positive 4 weeks after therapy ended. True reinfection was diagnosed in 11 of 105 patients between 3 and 18 months after therapy. The annual reinfection rate was 13%, based on a total follow-up of 84.7 patient years. Ulcer relapse occurred in 2 of 15 (13%) recrudescence cases and in 6 of 11 (55%) reinfection cases, but also in 4 of 73 (5%) H. pylori-negative patients. In Bangladesh, late recrudescence of H. pylori after eradication therapy occurs within the first 3 months. The reinfec...Continue Reading

Citations

Aug 2, 2002·Expert Opinion on Investigational Drugs·Paolo RuggieroGiuseppe Del Giudice
Apr 9, 2005·Journal of Clinical Gastroenterology·Maria A MesquitaJazon R S Almeida
Apr 9, 2005·Alimentary Pharmacology & Therapeutics·T-U WheeldonM Sörberg
Apr 12, 2006·European Journal of Gastroenterology & Hepatology·Jae Hee CheonIn Sung Song
Jun 18, 2009·World Journal of Gastroenterology : WJG·Kate L MandevilleShahid A Khan
Mar 26, 2013·Helicobacter·Ji Hoon JungJin-Ho Kim
Jun 12, 2004·Alimentary Pharmacology & Therapeutics·T-U WheeldonM Sörberg
Sep 1, 2005·The American Journal of Gastroenterology·Javier P Gisbert
Apr 20, 2007·FEMS Immunology and Medical Microbiology·Ann-Mari Svennerholm, Anna Lundgren
Mar 3, 2005·Journal of Gastroenterology and Hepatology·Nasrin ZendehdelFarideh Siavoshi
Sep 12, 2008·Helicobacter·Michael G Bruce, Heidi Ingrid Maaroos
Jun 27, 2006·Scandinavian Journal of Infectious Diseases·Mårten Kivi, Ylva Tindberg
Mar 6, 2008·Journal of Gastroenterology and Hepatology·Kwong Ming FockUNKNOWN Asia-Pacific Gastric Cancer Consensus Conference
Jul 24, 2014·BioMed Research International·Saurabh Kumar PatelGopal Nath
Feb 22, 2012·Current Gastroenterology Reports·Diana A Moya, Karen D Crissinger
May 18, 2016·Current Gastroenterology Reports·Caroline M den Hoed, Ernst J Kuipers
Mar 22, 2019·Chinese Medical Journal·Yan XueJin-Zhe Liu
Oct 3, 2020·Gut·Jyh-Ming LiouUNKNOWN Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM)
Apr 14, 2006·Alimentary Pharmacology & Therapeutics·B J McMahonA J Parkinson
Nov 26, 2003·The American Journal of Gastroenterology·Yelda Leal-HerreraOnofre Muñoz
Feb 23, 2007·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Scott B Citino, Linda Munson
Mar 12, 2008·World Journal of Gastroenterology : WJG·Yaron Niv
Feb 5, 2011·Nature Reviews. Gastroenterology & Hepatology·Emiko RimbaraDavid Y Graham
Jan 20, 2016·Scandinavian Journal of Gastroenterology·Josette RaymondCatherine Dauga
Dec 28, 2016·Journal of Digestive Diseases·Li Ya ZhouJia Ming Qian
Feb 28, 2019·Journal of Gastroenterology and Hepatology·Young Kwon ChoiHwoon-Yong Jung
Mar 1, 2005·Journal of Pediatric Gastroenterology and Nutrition·Anna Maria MagistàRuggiero Francavilla
Dec 25, 2004·European Journal of Gastroenterology & Hepatology·Abdallah A GunaidIain M Murray-Lyon
Aug 2, 2017·Journal of Gastroenterology and Hepatology·Varocha MahachaiDavid Graham
Oct 4, 2002·European Journal of Gastroenterology & Hepatology·Anne Feydt-SchmidtSibylle Koletzko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.